Newly synthesized rat glomerular [35S]proteoglycans were labelled in vivo after injecting Na2[35S]S04 intraperitoneally. At the end of the labelling period (7 h) the kidneys were perfused in situ with 0.01 % (w/v) cetylpyridinium chloride. This fixed proteoglycans in the tissue and increased their recovery 2-3-fold during subsequent isolation of glomeruli from the renal cortex. The glomeruli were fractionated by a modified osmotic lysis and detergent extraction procedure [Meezan, Brendel, Hjelle & Carlson (1978) Kay 0.68) accounted for 27 % and 28 % of the extractable heparan sulphate respectively and were not associated with the basement membrane fraction. HS1, HS2 and HS3 were also isolated from non-fixed glomeruli labelled in vivo but with much lower recovery. In glomeruli labelled in vitro, heparan sulphate accounted for only 35 % of the proteoglycans, the remainder being of the chondroitin sulphate type. Proteoglycans similar to HS1, HS2 and HS3 were present in glomeruli labelled in vitro but, in addition, a large, highly charged heparan sulphate (HSla) was extracted from the glomerular basement-membrane fraction of these glomeruli. It accounted for 6 % of the total heparan sulphate.
INTRODUCTION
The renal glomerulus consists of a tuft of capillaries surrounded by a capsule (Bowman's capsule). The lumen of each capillary is lined with a layer of fenestrated endothelial cells beneath which lies a specialized basement membrane. The foot processes of epithelial cells (podocytes) are attached to the abluminal side of the basement membrane. Blood filters through the capillaries, a protein-free filtrate collecting in the capsular space between the capillaries and Bowman's capsule, whilst plasma proteins and cellular elements are retained in the lumen. The mesangium, consisting of mesangial cells and an extracellular matrix, is located in the central core (axial region) of the glomerulus, in contact with the lumen of the capillaries where they branch out from the afferent arteriole through which arterial blood enters the unit (for a review of the structure, see ref. [1] ).
Proteoglycans in the glomerular basement membrane form the main charge and steric exclusion barriers to the trans-capillary passage of plasma proteins [1, 2] . Proteoglycans are also associated with the plasma membranes of the glomerular epithelial [3] and endothelial cells [2] and probably contribute to the charge barrier at these locations [2] . There is a loss of proteoglycans from the basement membrane and other glomerular sites in several conditions associated with proteinuria. These include human diabetic nephropathy [4, 5] , human congenital nephrotic syndrome [6] , experimentally induced diabetes [7] and experimental autologous immune-complex disease [8] . Knowledge of the biosynthesis, structure and metabolism of glomerular proteoglycans is therefore likely to be important in understanding the molecular basis underlying the development of proteinuria in these disorders.
There have been several recent reports on the biosynthesis of glomerular proteoglycans [9] [10] [11] [12] [13] , mainly based on experiments carried out in vitro. We report below on the development of a reliable method for investigating glomerular [35S]proteoglycan synthesis in vivo. By perfusing kidneys with cetylpyridinium chloride in vivo, newly synthesized glomerular proteoglycans were fixed in the tissue and subsequently recovered in yields 2-3-fold greater than from unfixed kidneys. Comparison of the proteoglycans isolated from glomeruli which had been labelled with [35S] sulphate in vivo with those from glomeruli labelled in vitro showed several striking differences as well as some similarities.
METHODS

35S-Labelling of glomerular proteoglycans
Female Wistar rats (-180 g body wt.) were injected twice, intraperitoneally, with 0.5 mCi/100 g body wt. of Na2[35S]S04 (300-600 mCi/mmol, NEN Research Products, Stevenage, Herts., U.K.). The injections (0.5 ml) were given at 3.5 h intervals. The animals were anaesthetized 3.5 h after the second injection. The kidneys were perfused with 10 ml of phosphate-buffered saline (Dulbecco's formula without calcium and magnesium, pH 7.2), followed by 0.01 % (w/v) cetylpyridinium chloride in phosphate-buffered saline (50 ml) (solution. A) at room temperature and at a maximum pressure of 213 kPa. The retrograde perfusion was carried out via a cannula inserted into the aorta just below the renal arteries. After perfusion the kidneys were removed and placed in solution A containing the proteinase inhibitors phenylmethanesulphonyl fluoride (0.001 M), N-ethylmaleimide (0.001 M), disodium-EDTA (0.01 M), benzamidine hydrochloride (0.005 M) and 6-aminohexanoic acid (0.1 M) (solution B). Glomeruli were isolated from the kidneys by passing the renal cortex [14] through graded sieves (106, 180 and 53 ,um mesh sizes; Endecotte, London, U.K.) with solution B at room temperature. Glomeruli retained on the smallest sieve were washed three times and resuspended in the same solution. After adequate mixing 50 ,1 of the suspension was taken up into a calibrated glass capillary tube for counting glomeruli under the phase contrast microscope.
For labelling experiments carried out in vitro, glomeruli were isolated from 18 kidneys under sterile conditions and cultured in Dulbecco's modified Eagle's Medium supplemented with fetal-calf serum (10 % v/v), Lglutamine (0.002 M), transferrin (5 jug/ml), insulin (0.66 i.u./ml), penicillin (100 units/ml) and streptomycin (100 #,g/ml), at 37°C in a 19:1 air/CO2 atmosphere.
After 2-3 h the medium was replaced with 6 ml of fresh medium containing 10 % of the normal MgSO4 concentration together with 150 ,sCi of Na2[35S]S04/ml, and supplements, as above. The incubation was continued for 24 h. The medium was decanted after centrifuging, proteinase inhibitors added to it (final concns. as above) and stored at -20 OC. Preparation and extraction of glomerular basement membranes A glomerular basement-membrane fraction was isolated by osmotic lysis and detergent extraction of glomeruli [15, 16] . Proteinase inhibitors were added for the lysis (as above) during the DNAase digestion (as above but without EDTA) and for the detergent extraction (as above but without EDTA and phenylmethanesulphonyl fluoride and with leupeptin, 100 jug/ ml). The method was also modified by carrying out the DNAase digestion step in 1.5 M-KCl/0.005 M-MgCl2/ 0.005 M-CaCl2 (pH 7.8). The high concentration of KCl was used to dissociate cetylpyridinium-proteoglycan complexes [17] ; in control experiments, it did not inhibit DNAase digestion of calf-thymus DNA. The supernatants from the osmotic lysis, DNAase digestion and deoxycholate extraction steps [15] were retained. The final basement-membrane preparation was washed twice with distilled water and then with 0.15 M-NaCl before extraction at 4°C for 18 h by tumbling in 8.0 M-urea/ 0.05 M-Tris/HCl buffer (pH 8.6) containing protease inhibitors (as above) [18] . The residue was recovered by centrifuging (15000 g, 30 min, 4 IC) and re-extracted with the same solution for a further 2 h. The supernatants were pooled. The urea-insoluble residue was extracted overnight with 4.0 M-guanidine hydrochloride/0.05 Msodium phosphate buffer (pH 7.0) containing proteinase inhibitors at room temperature. The residue was reextracted for a further 4 h with the same solution and the supernatants pooled. Any remaining residue was digested with papain and assayed for radioactivity (see below).
Measurement of 35S-radioactivity in macromolecules
Portions of the supernatants obtained above and extracts of the glomerular basement-membrane fraction were chromatographed on prepacked columns of Sephadex G-25 (PD-IO columns; Pharmacia) to measure 35S-labelled macromolecules [19] . A portion of whole glomeruli was digested with papain [17] , then treated with 0.5 M-NaOH for 1 h at room temperature, and the 35S-labelled glycosaminoglycans released were assayed for radioactivity as above.
Characterization of glomerular 135Sjproteoglyeans
Supernatants, extracts or culture media, containing [35S]proteoglycans were dialysed extensively against distilled water and then against 8.0 M-urea/0.05 Msodium acetate/0.1 % (v/v) Triton X-100/0.075 M-NaCl (pH 6.0) before fractionation on a DEAE-Sephacel column (7.0 mm x 40.0 mm) equilibrated with the same buffer, but containing 0.5% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonate instead of Triton X-100 (equilibration buffer). The column was eluted with equilibration buffer (5 ml), equilibration buffer containing 0.15 M-NaCl (5 ml) and then with equilibration buffer and an 0.15-0.75 M-NaCl gradient (46 ml) at a flow rate of 2.4 ml/h. Fractions (0.8 ml) were collected throughout and their 35S-radioactivity and conductivity measured.
The supernatant fraction from the deoxycholate extract of glomeruli (see above) was treated differently. The fraction was mixed with an equal volume of 8.0 Murea equilibration buffer and tumbled overnight at 4°C with 2 ml of DEAE-Sephacel gel. The mixture was then poured into a column and eluted as for the other fractions.
35S-Labelled peaks eluting from the DEAE column were pooled, dialysed into distilled water, divided into two parts and freeze-dried. Each was resuspended in a minimum volume of water, or in 50 mM-Tris/HCl/ 60 mM-sodium acetate/0.01 M-NaF (pH 8.0) [20, 21] . The aqueous portion was degraded with freshly prepared icecold HNO2 (4: 1, v/v) to remove heparan sulphate chains [22] [23] [24] . The reaction was terminated by neutralizing with 1.0 M-Na2CO3. The buffered portion was digested overnight with chondroitinase ABC (0.1 unit, 37 IC; Miles Biochemical Inc.) to remove chondroitin sulphate chains [20] . Proteinase inhibitors were not added to the digest, but as large heparan sulphate proteoglycans were isolated following chondroitinase ABC digestion, the enzyme did not appear to contain significant proteinase activity against proteoglycans. The digests were then chromatographed on a Sepharose CL-4B column (0.006 m x 1.5 m; Pharmacia) and eluted with 4.0 Mguanidine hydrochloride/0.05 M sodium acetate/0.1I% Triton X-100 at a flow rate of 2.4 ml/h. Fractions of 0.8 ml were collected and monitored for radioactivity. Peaks eluting from the Sepharose CL-4B column were pooled separately and concentrated to 0.5 ml using Centricon microconcentrators (Amicon). Each was treated with 0.05 M-NaOH containing 1.0 M-NaBH4 for 18 h at 45°C and then neutralized with glacial acetic acid [25] .
[35S]Glycosaminoglycans released in this reaction were chromatographed on a Sepharose CL-6B column (0.006 m x 1.5 m) and eluted under the same conditions as those described for Sepharose CL-4B chromatography.
RESULTS
Effect of cetylpyridinium chloride perfusion on recovery of glomeruli and glomerular proteoglycans
Recoveries of glomeruli from kidneys perfused with phosphate-buffered saline did not differ significantly from non-perfused kidneys (Table 1) . However, the recovery of glomeruli from kidneys perfused in situ with 0.01 % cetylpyridinium chloride was 20 % lower than for non-perfused kidneys. This lower recovery is likely to be due to slight shrinkage of the glomeruli, allowing the smallest to pass through the 53 ,um diameter sieve on which the majority were collected. Perfusion with higher concentrations of cetylpyridinium chloride (> 0.01 %) caused visible distortion of the shape, and shrinkage of the glomeruli, and a much reduced recovery from the sieving procedure (results not shown). The glomerular fraction obtained from kidneys perfused with 0.01 % cetylpyridinium chloride had a normal appearance under the phase-contrast microscope and was free of other contaminating tissue structures.
When examined under the electron microscope basement-membrane preparations from cetylpyridinium chloride-perfused kidneys contained some acellular glomerular 'ghosts', still surrounded by a Bowman's capsule, together with isolated loops of basement membrane. Basement membrane preparations from phosphate-buffered saline-perfused kidneys contained only isolated loops of membrane. Some mesangial matrix and chromatin-like material was present in basement-membrane preparations from both sources, as reported by others [26] .
The effect of perfusion of kidneys in situ on the recovery of 35S-labelled proteoglycans in glomeruli isolated by the sieving procedure was assessed. Ten animals were labelled with [35S]sulphate in vivo for 7 h. Then the rats were anaesthetized and the left kidney perfused with 0.01% (w/v) cetylpyridinium chloride. Both kidneys were removed and their respective glomeruli isolated, counted, digested with papain, and the [35S]-glycosaminoglycans present were estimated by PD-10 column chromatography. Glomeruli from the kidney which had been perfused with cetylpyridinium chloride contained approx. 2.6 times more [35S]glycosaminoglycan than those isolated from non-perfused kidneys (Table 2) . Silver grain counts of autoradiographs of 0.5,um thick sections of perfused and nonperfused glomeruli showed approx. twice as many Table 3 . Release of 35S-labelled macromolecules from glomeruli during isolation of the basement-membrane Glomeruli were labelled either in vivo (7 h), or in vitro (24 h), as described in the text. In experiments carried out in vivo the kidneys were perfused at the end of the labelling period with either cetylpyridinium chloride (CPC) or phosphate-buffered saline (PBS). A basement-membrane fraction was prepared from the glomeruli using a modification of the Meezan fractionation scheme. 35S-Labelled macromolecules released into the supernatant at each stage of the fractionation were measured by PD-10 column chromatography. 35S-Labelled macromolecules in the basement membrane were extracted sequentially with 8 M-urea and 4 M-guanidine hydrochloride; the percentage shown is the sum for both extracts. Finally the residue was digested with papain. 35S-Labelled macromolecules released into the incubation medium of the glomeruli labelled in vitro were also estimated, and accounted for 19% of the total synthesized. (Table 4 ). The HS1 variety are heterogeneous in charge. HS1 isolated from the basement membrane accounted for 31 % of this class, and, therefore, by extrapolation, for 11.6% of the total extractable glomerular 35S-labelled proteoglycans. HS2 and HS3 were extracted from the glomeruli during the DNAase digestion. The Kav of HS3 is compatible with it being a single heparan sulphate chain, but this was not confirmed because of the low amount of radioactivity available. The same three classes of heparan sulphate proteoglycans were isolated from glomeruli labelled in vivo which had been perfused with phosphate-buffered saline alone, but in a ratio of 50:37:13 (HSI /HS2/HS3). Recovery of HS1 and HS2 from unfixed glomeruli was decreased by 50 % or more, whilst recovery of HS3 was even lower. In the absence of cetylpyridinium chloride perfusion only about 3 % of the total extractable 35S-labelled heparan sulphate proteoglycans were found associated with the glomerular basement-membrane fraction.
35S-macromolecules
The heparan sulphate-containing molecules isolated from glomeruli labelled in vitro (Table 5) have both similarities with, and differences from, those detected in vivo. A large, highly charged molecule, HSI(a), extracted from the basement-membrane fraction ( Table 4 . Glomerular heparan sulphate proteoglycans detected after labelling in vivo and renal perfusion in situ with cetylpyridinium chloride Rats were labelled in vivo (7 h) after which their kidneys were perfused in situ with cetylpyridinium chloride. Glomeruli were isolated from the renal cortex by sieving and subjected to hypotonic lysis, DNAase digestion and deoxycholate extraction, to obtain the basement-membrane fraction. The latter was extracted with urea and guanidine hydrochloride. latter. Similarly, CS5 has the same charge as CS3 (Table  6 ) and both have the same chain size (K8V, Sepharose 6B, 0.60), suggesting that one is a product of the other.
DISCUSSION
Previous investigations on the biosynthesis of glomerular [35S] proteoglycans have utilized techniques of labelling in vivo [9, 10, 13, 27] , organ perfusion ex situ with medium containing [35S]sulphate [7, 11, 28] [10, 13, 29] . Experiments based on labelling in vivo or organ perfusion ex situ involved subsequent isolation of glomeruli by the well-established sieving technique. Our studies show that if the glomerular proteoglycans are not fixed by perfusion of the kidney in situ following the labelling period, up to 60 % of newly synthesized glomerular proteoglycans are lost during sieving. Previous characterization studies have therefore been based on only about half of the total population of 35S-labelled glomerular proteoglycans.
Whilst investigations based on techniques of labelling in vitro do not suffer from recovery problems, it is clear from our results and from those of others [10, 12, 13] Perfusion of the kidney in situ with Karnovsky's aldehyde fixative was used for quantitative electronmicroscopic autoradiography of glomerular basementmembrane proteoglycans [30] . Cetylpyridinium chloride is a convenient fixative for chemical investigations since, as used here, it does not interfere with the isolation of intact glomeruli and can be readily dissociated from the proteoglycans subsequently [17] . Dissociation was achieved in our experiments by raising the concentration of KCI in the DNAase digestion buffer to 1.5 M [17] , but it may be carried out at a later stage during the isolation of glomerular basement membrane if desired.
In our experiments carried out in vivo the labelling protocol was designed to achieve maximal labelling of proteoglycans within a relatively short period. Peak blood radioactivity was attained approx. 30 min after injecting [35S]sulphate intraperitoneally, and fell to 50 % of maximal levels, 3.5 h after the injection. Thus to achieve optimal blood levels of radioactivity each animal received two injections, 3.5 h apart, and was killed after a further 3. There is agreement therefore that in experiments both in vivo and in vitro, a heparan sulphate proteoglycan of about this hydrodynamic size, with an estimated molecular mass of 130000 Da using glycosaminoglycan standards [11] , is the major glomerular basement-membrane proteoglycan synthesized in the rat. Parthasarathy & Spiro [31] characterized chemically the heparan sulphate proteoglycan extracted from bovine glomerular basement membrane and concluded that it consisted of a cluster of four heparan sulphate chains linked to one end of a core protein with an overall molecular mass of 200000 Da. Whether the variation in size of the molecule between species is real, or due to methodological differences between laboratories, is unknown.
HS1 proteoglycans of the same size as those isolated from the basement-membrane fraction were also released during the DNAase digestion and the deoxycholate extraction of glomeruli (Table 4) . They may be associated with the plasma membranes of glomerular cells or with the mesangial matrix. There is evidence indicating that the heparan sulphate proteoglycans of the glomerular basement membrane are immunologically distinct from those located in other parts of the glomerulus [3, 32] . HS2 and HS3 may also be located at sites in the glomerulus distinct from the basement membrane. The present results do not indicate whether or not HS2 is derived from processing of one or other HS1 molecules, or whether HS3 is derived from HS1 or HS2.
The experiments carried out in vitro (Tables 5 and 6 ) demonstrate the different state of proteoglycan synthesis in cultured glomeruli compared with the state in vivo. Most ofthe proteoglycans synthesized in our experiments carried out in vitro have properties which are very similar to those described recently by Klein et al. [13] for cultures of isolated rat glomeruli. Thus our HS2 (glomerular), HS2 (culture medium), CS3 (glomerular) and CS2 (culture medium) have almost identical properties to proteoglycans HStIA, HSml, DStIA and DSMII, reported by Klein et al. [13] , when you compare (a) their elution positions from DEAE-Sephacel columns and (b) the K,y of their glycosaminoglycan chains on Sepharose CL-6B. However, these authors did not report the highly charged heparan sulphate (HSla; Table 5 ) or chondroitin sulphate (CS1; Table 6 ) proteoglycans which were synthesized by glomeruli in our experiments carried out in vitro. Synthesis of a highly sulphated chondroitin sulphate by isolated glomeruli has been observed by Kobayashi et al. [33] and the molecule appears to be the product of mesangial cells [34] . Mesangial matrix is a contaminant of the glomerular basement-membrane fraction (see above) from which CS1 was extracted in our experiments. HSI(a) was also extracted from this fraction. Whether it is a component of the basement membrane, or a precursor of other basement-membrane heparan sulphate proteoglycans, is not known at present. Neither can we rule out the possibility that it is synthesized as an artefact of experimental conditions in vitro.
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